TheEdgeResearch
Home / Stocks / AZTA

Azenta, Inc. (AZTA)

NASDAQ Healthcare Medical - Instruments & Supplies
$33.22 ▼ -0.51%
Market Cap
$1.53B
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Beta
1.37
52-Wk Range
15.93-41.73
CEO
John Marotta
Country
US
Currency
USD

Azenta, Inc. operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Burlington, MA, US. The stock last traded at $33.22, down 0.51% on the session, giving a market capitalisation of $1.53B. On trailing twelve-month figures it carries a trailing P/E of -12.08, a net margin of -20.0%. Its beta of 1.37 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-12.08
Price / Sales
2.49
Price / Book
1.00
EV / EBITDA
-14.44
Gross margin
44.0%
Operating margin
-3.5%
Net margin
-20.0%
Return on equity
Debt / equity
0.04
Current ratio
2.50
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Select
Employees
3,000
IPO date
1995-02-02
Headquarters
Burlington, MA, US
About Azenta, Inc.

Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.

Comparable companies

Azenta, Inc. is most often compared with the following Healthcare names:

BLFSESTAEVOKMTSNEOGNVCRSDGRSTAASYRETDOC
More research on AZTA
AZTA technical analysis AZTA TheEdge Score Compare against peers
Open full interactive analysis & DCF →